Hjem › Mantelcellelymfom › Michigan
Mantelcellelymfom kliniske forsøg i Michigan
8 studier for Mantelcellelymfom søger deltagere på steder i Michigan.
Byer i Michigan
Officiel studietekst (engelsk)
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- McLaren Cancer Institute-Bay City, Bay City
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- og 26 flere
RekruttererFase 3
Alder 60 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT05976763A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
- University of Michigan, Ann Arbor
- The Cancer and Hematology Centers, Grand Rapids
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06742996A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Karmanos Cancer Institute, Detroit
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT05006716A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- University of Michigan Comprehensive Cancer Center, Ann Arbor
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07101328A Study of APG-3288 in Relapsed/Refractory Blood Cancers
- START Midwest, Grand Rapids
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 30. jul. 2026 · NCT07424833DALY II USA/ MB-CART2019.1 for DLBCL
- University of Michigan, Ann Arbor
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT04792489Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- University of Michigan, Ann Arbor
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. apr. 2026 · NCT03523975SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Ann Arbor
- Massive Bio SYNERGY-AI site, Lansing
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.